US EditionPublished • loading... • Updated
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care – Ortho Spine News
–Public-private partnership aims to improve osteoarthritis research, diagnosis and treatment––PROBE will leverage data from over 70 million individuals across multiple OA cohorts and real-world registries– BRISBANE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Pacira Biosciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced it has joined the PROBE
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care – Ortho Spine News
–Public-private partnership aims to improve osteoarthritis research, diagnosis and treatment––PROBE will leverage data from over 70 million individuals across multiple OA cohorts and real-world registries– BRISBANE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) — Pacira Biosciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced it has joined the PROBE
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
